N-lorem foundation focuses on creating individual treatment for patients with ultra-rare diseases caused by genetic mutations.
n-Lorem Foundation has raised $1.0M in total funding. The most recent round was Grant. The last funding was announced in September 2022.
n-Lorem Foundation's investors include Solve FSHD.
n-Lorem Foundation is headquartered in California City, United States.
N-lorem foundation focuses on creating individual treatment for patients with ultra-rare diseases caused by genetic mutations.
n-Lorem Foundation is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"n-Lorem Foundation — Funding & Investors." VCBacked, September 13, 2022, https://www.vcbacked.co/company/n-lorem-foundation. Accessed August 14, 2026.
VCBacked. (2022). n-Lorem Foundation — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/n-lorem-foundation
{{cite web |title=n-Lorem Foundation — Funding & Investors |url=https://www.vcbacked.co/company/n-lorem-foundation |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated